Showing results (421-430 of 463) with videos related to
Sort By:
Pageof 47
Clinical Genetics|October 19, 2010
Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel diseaseZ Lin, J P Hegarty, J A Cappel, et al.Ebiomedicine|April 19, 2022
Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster modelChristopher Käufer, Cara S Schreiber, Anna-Sophia Hartke, et al.International Journal of Immunopathology and Pharmacology|January 16, 2010
Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrilsH Wilms, P Rosenstiel, M Romero-Ramos, et al.European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 6, 2003
Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel diseaseK King, A Moody, S A Fisher, et al.Frontiers in Health Services|September 11, 2023
The VA National TeleNeurology Program implementation: a mixed-methods evaluation guided by RE-AIM frameworkTeresa M Damush, Jayne R Wilkinson, Holly Martin, et al.Genes and Immunity|October 16, 2009
A 3' UTR transition within DEFB1 is associated with chronic and aggressive periodontitisA S Schaefer, G M Richter, M Nothnagel, et al.Nature|March 3, 2022
Recovery time of a plasma-wakefield acceleratorR D'Arcy, J Chappell, J Beinortaite, et al.Genes and Immunity|April 24, 2009
Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseasesX Yu, S Wieczorek, A Franke, et al.Gut|January 15, 2002
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gammaH Tilg, C van Montfrans, A van den Ende, et al.Gastroenterology|December 13, 2000
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study GroupS Schreiber, R N Fedorak, O H Nielsen, et al.Pageof 47